GXMC
CBPO

Global X Management Company’s China Biologic Products Holdings, Inc. CBPO Stock Holding History

Global X Management Company’s Portfolio CBPO Stock Details CBPO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-266
Closed -$30K – 1214
2017
Q2 		$30K Buy
+266
New +$29.7K ﹤0.01% 1048

Other funds holding CBPO

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
HIM
Hermes Investment Management London Uk, United Kingdom $7.52B AUM 20.67% 1-Year Est. Return

Global X Management Company's CBPO Position: Q3 2017 in Review

Global X Management Company sold out of China Biologic Products Holdings, Inc. (CBPO) in Q3 2017, closing a stake of 266 shares — an estimated $30K sold.

Global X Management Company first reported a position in CBPO in Q2 2017 and held it in 1 quarter. The position peaked at $30K in Q2 2017. 94 funds tracked by Wall St. Rank hold CBPO as of Q3 2017.

  • Global X Management Company reported no remaining China Biologic Products Holdings, Inc. position as of Q3 2017 after selling out during the quarter.
  • Global X Management Company sold 266 China Biologic Products Holdings, Inc. shares in Q3 2017, an estimated $30K.
  • Global X Management Company first reported a position in China Biologic Products Holdings, Inc. in Q2 2017 and held it in 1 quarter.
  • Global X Management Company's China Biologic Products Holdings, Inc. position peaked at $30K in Q2 2017.
  • 94 funds tracked by Wall St. Rank held China Biologic Products Holdings, Inc. as of Q3 2017.

Based on Global X Management Company's 13F filing for Q3 2017, filed 3 Nov 2017.